Showing results (141-150 of 340) with videos related to

Sort By:
Pageof 34
Biomedicines|October 23, 2021
The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 ExpressionCiniso Sylvester Shabangu, Phumelele Yvonne Siphepho, Chia-Yang Li, et al.
Plos One|August 9, 2019
Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patientsMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
Gut|September 8, 2006
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis CMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 29, 2007
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensationChia-Yen Dai, Ming-Lung Yu, Ming-Yen Hsieh, et al.
The Kaohsiung Journal of Medical Sciences|October 21, 2017
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agentsJee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2017
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacyJee-Fu Huang, Yu-Min Ko, Chung-Feng Huang, et al.
The Journal of Infectious Diseases|January 28, 2010
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis CChung-Feng Huang, Jeng-Fu Yang, Chia-Yen Dai, et al.
Oncotarget|December 2, 2017
The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinomaChih-Wen Lin, Chih-Che Lin, Po-Huang Lee, et al.
Antiviral Research|April 3, 2007
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis BChia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Hepatology Communications|April 13, 2019
Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C InfectionTomi Jun, Yao-Chun Hsu, Shintaro Ogawa, et al.
Pageof 34